drugset / Trial / NCT00427258

Study Evaluating MOA-728 Administered in Healthy Men

NCT00427258

Phase 1 Withdrawn Bausch Health Americas, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Absorption, distribution, metabolism, and excretion (ADME) study with 14C in healthy young men.

Timeline

Start
2010-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified

Indications

No indication recorded.